Tirzepatide studies: 457 papers with results
Page 7 of 10
- Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity.
Rodriguez PJ · JAMA internal medicine · 2024
Observational study · 8 results
- Comparative effectiveness of tirzepatide and DPP-4 inhibitors in type 2 diabetes with heart failure.
Mortada I · Diabetes & vascular disease research · 2026
Observational study · 5 results
- Real-World Effectiveness of Semaglutide and Tirzepatide Compared With Bariatric Surgery.
Brown A · Obesity (Silver Spring, Md.) · 2026
Observational study · 4 results
- Relative efficacy of GLP-1 and GLP-1/GIP receptor agonists in the prevention of alcohol-use disorders using a target trial emulation approach.
Henney AE · Diabetes, obesity & metabolism · 2026
Observational study · 6 results
- Early Fasting Serum Glucose or Weight Reduction With Tirzepatide and Metabolic Outcomes in People With Type 2 Diabetes: A Post Hoc Analysis of the SURPASS Trials.
Giorgino F · Diabetes care · 2025
Observational study · 9 results
- Association of tirzepatide with glycaemic control and weight loss in a real world cohort of patients with type 2 diabetes from the United States.
Mody R · Diabetes, obesity & metabolism · 2025
Observational study · 5 results
- Six-Month Real-World Effectiveness, Persistence and Safety of Low-to-Moderate Dose Tirzepatide in Adults With Obesity: A Multicentre Observational Study.
Angelopoulos N · Diabetes, obesity & metabolism · 2026
Observational study · 11 results
- Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States.
Hankosky ER · Diabetes & metabolism · 2025
Observational study · 5 results
- Evaluation of Insulin Dosage After the Addition of Tirzepatide Compared With Semaglutide or Dulaglutide in Patients With Type 2 Diabetes.
McKone DB · Diabetes spectrum : a publication of the American Diabetes Association · 2025
Observational study · 14 results
- A real-world study of tirzepatide for weight loss in adults without diabetes mellitus.
Angelopoulos N · International journal of obesity (2005) · 2026
Observational study · 10 results
- Impact of Tirzepatide on diet-related quality of life and treatment satisfaction in people with type 2 diabetes mellitus: a retrospective cross-sectional study.
Kato S · Diabetes research and clinical practice · 2025
Observational study · 5 results
- Comparative Analysis of Efficacy and Safety of the Glucagon-Like-Peptide-1 Receptor Agonists Tirzepatide and Semaglutide in Solid-Organ Transplant Recipients.
El Khatib O · Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation · 2026
Observational study · 20 results
- Short-term effect of tirzepatide on serum calcitonin in adults with obesity.
Angelopoulos N · Endocrine · 2026
Observational study · 3 results
- Effects of the switch from dulaglutide to tirzepatide on glycemic control, body weight, and fatty liver: a retrospective study.
Sawamura T · Journal of diabetes and metabolic disorders · 2024
Observational study · 8 results
- Evaluating the therapeutic impact of tirzepatide in people with partial lipodystrophy.
Mandour MO · The Journal of clinical endocrinology and metabolism · 2026
Observational study · 4 results
- Tirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence of Efficacy and Safety.
Vinciguerra F · Obesity surgery · 2026
Observational study · 5 results
- Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?
Meral R · Diabetes care · 2025
Observational study · 6 results
- Improving glycemic control: transitioning from dulaglutide to tirzepatide in patients with type 2 diabetes undergoing hemodialysis.
Otsuka E · Frontiers in pharmacology · 2024
Observational study · 7 results
- Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis.
Guirguis A · European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2024
Observational study · 16 results
- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase®).
McIntyre RS · Journal of affective disorders · 2025
Observational study · 13 results
- Association of Glucagon-Like Peptide-1 Receptor Agonists With Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 Countries.
Lakhani M · American journal of ophthalmology · 2025
Observational study · 12 results
- Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events.
He L · Frontiers in pharmacology · 2024
Observational study · 17 results
- Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice.
Krüger N · Nature medicine · 2026
Observational study · 5 results
- Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis.
Guo H · Frontiers in pharmacology · 2024
Observational study · 12 results
- Real-world use and effectiveness of tirzepatide among individuals without type 2 diabetes: Results from the Optum Market Clarity database.
Hankosky ER · Diabetes, obesity & metabolism · 2025
Observational study · 6 results
- Glucagon-like peptide-1 receptor agonists and impaired gastric emptying: a pharmacovigilance analysis of the US Food and Drug Administration adverse event reporting system.
Huang H · British journal of anaesthesia · 2025
Observational study · 10 results
- The impact of approved anti-obesity medications on osteoarthritis.
Baser O · Expert opinion on pharmacotherapy · 2024
Observational study · 7 results
- Otolaryngologic Side Effects of GLP-1 Receptor Agonists.
Khan FI · The Laryngoscope · 2025
Observational study · 20 results
- Weight loss interventions and obesity-associated cancers in people with type 2 diabetes and overweight/obesity: A real-world observational study.
Ipaye T · Diabetes, obesity & metabolism · 2025
Observational study · 6 results
- Revisional endoscopic sleeve gastroplasty versus semaglutide and tirzepatide for weight recidivism after sleeve gastrectomy.
Bahdi F · Clinical obesity · 2025
Observational study · 21 results
- Semaglutide-induced Wernicke encephalopathy: a comprehensive analysis.
Gras C · European journal of clinical nutrition · 2025
Observational study · 6 results
- A treat-to-target approach for obesity management: A post hoc analysis of the SURMOUNT-5 trial.
le Roux CW · Diabetes, obesity & metabolism · 2026
Observational study · 6 results
- Muscle atrophy associated with glucagon-like Peptide-1 receptor agonists: A population-based observational study.
Kwan ATH · Clinical nutrition (Edinburgh, Scotland) · 2026
Observational study · 3 results
- Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs in the FDA Adverse Event Reporting System.
Seijas-Amigo J · International journal of clinical pharmacy · 2026
Observational study · 8 results
- A Descriptive Analysis from VigiAccess on Drug-related Problems Associated with the Glucagon-like Peptide-1 Receptor Agonists.
Amirthalingam P · Current drug safety · 2026
Observational study · 18 results
- Dysesthesia associated with GLP-1 agonist therapies: data-mining analysis and literature review.
Laroche ML · European journal of clinical pharmacology · 2026
Observational study · 8 results
- Glucagon-like peptide-1 receptor agonist-associated injection site and dermatologic reactions.
Elgindi D · Clinics in dermatology · 2026
Observational study · 8 results
- Real-World Comparative Weight Loss of GLP-1 Receptor Agonists in the All of Us Research Program: A Retrospective Cohort Study.
Hwang I · Drug design, development and therapy · 2026
Observational study · 9 results
- Optic Ischaemic Neuropathy in Incretin-Based Therapy: A Comparative Analysis of Real-World Safety Data.
Kakkar AK · Diabetes, obesity & metabolism · 2026
Observational study · 5 results
- Evaluation of the safety profile of glucagon-like peptide-1 receptor agonists: a focus on thyroid cancer-related adverse events by using the European pharmacovigilance database.
Anatriello A · Pharmacological reports : PR · 2026
Observational study · 6 results
- Toward Precision Obesity Pharmacotherapy: Using the Eating Behavior Phenotype Scale (EFCA) in Real-World Clinical Practice.
Pineda-Wieselberg RJ · Nutrients · 2026
Observational study · 9 results
- Association of tirzepatide with erectile dysfunction in people with type 2 diabetes.
Cowart K · Journal of diabetes and its complications · 2025
Observational study · 3 results
- Characteristics and Treatment Patterns of People Without Type 2 Diabetes Diagnoses Who Use Tirzepatide in the United States.
Gibble TH · Clinical therapeutics · 2025
Observational study · 5 results
- Effect on Hemoglobin A1c (HbA1c) and Body Weight After Discontinuation of Tirzepatide, a Novel Glucose-Dependent Insulinotropic Peptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist: A Single-Center Case Series Study.
Kubota M · Cureus · 2023
Case report or series · 7 results
- Tirzepatide-Induced Injection Site Reaction.
Mizumoto J · Cureus · 2023
Case report or series · 3 results
- Effectiveness of the Dual GIP/GLP1-Agonist Tirzepatide in 2 Cases of Alström Syndrome, a Rare Obesity Syndrome.
Ferch M · The Journal of clinical endocrinology and metabolism · 2025
Case report or series · 6 results
- A Case Report of Systemic Allergic Reaction to the Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonist Tirzepatide.
Le TTB · Cureus · 2024
Case report or series · 1 result
- Allodynia and Dysesthesia Associated With Semaglutide and Tirzepatide.
Ahern S · Cureus · 2025
Case report or series · 4 results
- Acute Pancreatitis Caused by Tirzepatide.
Mando N · Cureus · 2024
Case report or series · 2 results
- Lithium toxicity following a change from semaglutide to tirzepatide for weight loss management.
Burson JR · The mental health clinician · 2026
Case report or series · 3 results